CYP2J2(∗)7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

Chemotherapy-induced hematologic toxicity is the primary reasons of dose reductions and/or delays, low relative dose intensity (RDI), and predicts anticancer response. We investigated the incidence and predictors of chemotherapy-induced hematologic toxicities and reduced RDI in Ethiopian breast canc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Ahmed, Jemal Hussien, Makonnen, Eyasu, Yimer, Getnet, Seifu, Daniel, Bekele, Abebe, Assefa, Mathewos, Aseffa, Abraham, Howe, Rawleigh, Fotoohi, Alan, Hassan, Moustapha, Aklillu, Eleni
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527746/
https://ncbi.nlm.nih.gov/pubmed/31139078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00481
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados